Member Info for MasterRSI

no pus ...is the answer a gamble can not be taken seriously if you want to gamble with IMM sure you cannot understand it but is how it works, and the same applies any comments room you put them down while you can ( hit them harder if you really enjoy the pain )

amazing how a fool gambling trying to tell you what to do empty headless come to mind

re - today's price so far really is back to before closing yesterday 38.70 v 39p or better, but it looks like down due to the Higher closing UT 39.60p Looking good for another rise today

A few early sells at the start of the day got the stock lower, but some took advantage of that and is recovering fast, some seem to think it was good to sell on yesterday's rise

UT at a higher price 39.60p 16:35:18 39.60p 14,556 UT

Got the message the one below is the same person as "pus" The reporting ABUSE ( double and most likely many more alias ) has to be done , enough is enough kevioio Member Since: Thu, 8th Feb 2018 much the same as ... "pus" around the same dates and all post for IMM only

the truth hurts, but the worse is not to have money to buy any shares, so sell the bad nickname for money so "pus" being paid for deramping is the conclusion

EXPOSED the culprit of ...pus Nolupus ....Member Since: Tue, 13th Feb 2018 all IMM post for the last 30 days no shares on IMM and mentioning Benlysta once too often could be a member of the opposition drug

Just like everything put time on doing some learning. there are plenty of places to start with Indicators are the first to go with ... RSI, stochastic and MACD next Bollinger Bands Fibonacci retracement, etc chart with many of those all at oversold http://charts.moneyam.com/Chart.aspx?Provider=EODIntra&Code=IMM&Size=800*550&Skin=GreenRed&Type=3&Scale=0&Cycle=DAY1&Span=MONTH1&OVER=AreaBB;MA(26)&IND=MACD(26,12,9);RSI(14);SlowSTO(14,3,3)&Layout=2Line;Default;Price;HisDate&XCycle=&XFormat=

From the "UPS" thread earlier ...... KEEP an EYE IMM 38.35p ( 38.20/38.50p) Looks ready to turn for the better after the 50% retrace on the last rise. Had a retrace at 38.2% and bounce, now is the turn on the 50%, at 34.46p yesterday, but this time to do over the previous Intraday 50p Retrace chart http://uk.advfn.com/p.php?pid=chartscreenshot&u=bpwcF4uB7dNjD6OezV2ODEPezMQOkI9b

I will say it again......... The "No" is an unfriendly lupus too many negatives make a POSITIVE I think someone is trying to discredit ( himself/her) ---------- signs of turning on the share price

Translated from the German report ...... New lupus drug: not immunosuppressive, fewer side effects - 23. April 2018 . Drucken - PHASE III STUDIE LupuzorTM is the first non-immunosuppressive drug for lupus. Now there are promising data from the phase III clinical trial. A marketing approval is considered likely this year. New treatment for lupus: LupuzorTM is about to be launched Lupus patients can hope for a new drug: The Phase III clinical trial for LupuzorTM has just been successfully completed. This is the last phase before market approval. Also known as Rigerimod, IPP-201101 and P140, LupuzorTM has been used in conjunction with basic medicines in nearly 70 percent of patients. With nearly 60 percent of patients treated with placebo and basic drugs responding positively, LupuzorTM did not prove superior, but it was equally effective. Consider the side effects However, the new drug was superior in terms of safety: the study did not show any serious side effects as observed with standard drugs. In addition, LupuzorTM showed a response rate of 61.5 percent in patients who had anti-dsDNA autoantibodies, compared to 47.3 percent of patients receiving only placebo. Lupus is an incurable autoimmune disease in which the body's immune system attacks healthy tissue. Previous therapies suppress the immune system or inhibit overstimulated B cells. In contrast, the new drug LupuzorTM suppresses only CD4T cells before they can overstimulate the lupus-causing B cells. Thus, lupus is stopped while healthy defense mechanisms remain intact. Scientists are talking about an immune modulator. Market launch planned for 2018 The Phase III clinical trial began in late December 2015 with one patient in the US and later expanded to Europe. A total of 202 patients were included, divided into two groups: the first group received LupuzorTM and the second group a placebo. All patients also took other medications such as steroids, antimalarials, methotrexates, etc. LupuzorTM was developed by the team of researchers led by Sylviane Muller from the Laboratory of Immunopathology and Therapeutic Chemistry of the French Center for Scientific Research CNRS and has already been successfully tested by ImmuPharma France in Phase I and II clinical trials. Due to the positive Phase III study results, the manufacturer now wants to apply for approval quickly. The launch in the US and five EU countries is scheduled for 2018.

The "No" is an unfriendly lupus too many negatives makes it POSITIVE

poor souls they could not hold into any more pain

Since the bounce back to 50p, The order book has managed to do a perfect 38.2% retracement. sometimes things work this way but it seems too real for a couple day to reached 38.10p and bounce back from there. chart of the 38.2% retrace https://uk.advfn.com/p.php?pid=chartscreenshot&u=bpwcF4uB7dNjD6OezV2ODEPezMQOkI9b

Big rise today as the sellers are not there anymore

sometimes one has to wait a bit to see the full picture Buyers are back at those lower price, if the price is marked up too fast

So is the share price, has gone to 0.70p bid not seeing for a week

A few trades 14 already this morning, and as usual, MMs moving prices around, so up and down, but looking at the trades the buyers seem more robust so far after the 2x5K

bounce after the MMs marked down together earlier